Lock In Your Returning Customer Discount Today
Your £25 Loyalty Discount Protects Against Rising Mounjaro Costs
Whilst Mounjaro prices increase across the UK market, EverydayMeds returning customers maintain consistent savings. Your loyalty discount reduces every pen by £25 - from £169.99 to £144.99 for 2.5mg, £199.99 to £174.99 for 5mg, and £269.99 to £244.99 for 10mg doses. This prescription-only medication designed to support weight management alongside diet and exercise becomes more affordable with each reorder.
Streamlined Reordering Process for Existing Patients
Your previous clinical assessment expedites approval - most returning customers receive prescriptions within 24 hours using our express service. Our GPhC-registered clinicians review your progress and adjust dosing as needed. Whether you're continuing 7.5mg (£224.99 with discount) or progressing to 12.5mg (£274.99 with discount), reordering takes minutes through your account dashboard.
Bundle Savings Stack With Loyalty Discounts
Combine your £25 returning customer discount with multi-pen bundles for maximum value. The Progress Duo (5mg + 7.5mg) drops from £409.99 to £384.99, whilst the Advance Duo (7.5mg + 10mg) reduces from £489.99 to £464.99. Three-month supplies through our Progress Trio become £649.99 instead of £674.99 - protecting your budget against further market increases.
Priority Stock Allocation for Loyalty Members
Returning customers receive priority access to Mounjaro stock during supply constraints. Whilst new patients may face delays, your loyalty status ensures consistent access to this MHRA-monitored medication. Our pharmacy maintains dedicated inventory for existing prescriptions, supporting your weight management journey without interruption.
Secure Your Next Supply Before Price Rises
Market analysts predict further Mounjaro price increases throughout 2026. Your returning customer status locks in current discounted rates regardless of future RRP changes. Complete your clinical review today to maintain £25 savings on every order. Express approval available for seamless prescription continuity.
